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Public awareness of the role of genetics in disease continues to expand along with 
the use of direct-to-consumer genetic testing (DTC-GT). One subset of customers taking 
advantage of the growing DTC-GT market is adoptees. Prior research has shown that 
adoptees appear to be more motivated than non-adoptees to learn about their genetic 
disease risk but have similar responses to health-related information acquired through 
DTC-GT. In this exploratory qualitative study, fourteen adoptees were asked about their 
motivations for pursuing DTC-GT; satisfaction with results; emotions throughout the 
process; and interest in meeting with a genetic counselor. Motivations for pursuing DTC-
GT fell into three categories: 1) identity-seeking, 2) a desire for health information, and 
3) general curiosity. Adoptees reported a variety of emotional responses to DTC-GT but 
had more profound emotional reactions to ancestral information, related to both ethnicity 
and biological familial connections. Finally, the majority of adoptees found value in 
meeting with a genetic counselor, either for themselves or for their family given certain 
circumstances. This study highlights adoptees’ experiences in their pursuit of genetic 
information. By understanding this population’s journey with DTC-GT, genetic 
counselors and genetics professionals can be better equipped to address the concerns and 
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Chapter 1. Background 
 
1.1 Overview 
Adoption is a familiar concept in the United States, and the majority of Americans 
have been exposed to adoption at some point in their lives (Dave Thomas Foundation for 
Adoption, 2002). Among adopted individuals, it is not uncommon to experience a lack of 
family health history, and for adult adoptees, this lack of family information may be even 
more prevalent (Corder, 2012; May, Strong, Khoury, & Evans, 2015; Moe, 1998). 
Currently, DTC-GT provides consumers with the opportunity to order genetic testing 
without the assistance of a medical professional (What is Direct-to-Consumer Genetic 
Testing?) The DTC-GT industry continues to expand, and many DTC-GT consumers are 
driven by a curiosity about genes and genetic disease risk (Sanderson et al., 2015; Gollust 
et al., 2012; Su, Howard, & Borry, 2011; Baptista et al., 2016). Adoptees purchasing 
DTC-GT may be particularly motivated by this pursuit of genetic risk information, and 
for this subset of customers, DTC-GT may be viewed as the only available source of 
family history information (Corder, 2012; Crouch, Shankar, & Tabor, 2014; Hill & 
Edwards, 2009).   
This background will explore several factors: adoption in the United States; the 
DTC-GT market and its development; risk perception and factors affecting its 
development; and where adoptees and genetic professionals fit into the DTC-GT market. 
The goal is that this will help to gain a better understanding of the unique situation of 
adoptees navigating this newfound source of genetic information. 
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1.2 Adoption in the United States 
Adoption can be described as a “legal process in which a child is raised by 
someone other than his or her biological parents” (Kavanaugh & Fiorini, 2016; Corder, 
2012). The concept of adoption is not new, and written laws regarding adoption have 
been uncovered throughout several major parts of history (Moe, 1998; DellaCava, 
Phillips, & Engel, 2016); for example, laws concerning adoption can be found in the 
Babylonian Code of Hammurabi, in Hindu law, and in the Old and New Testament. The 
idea of adoption continues to become increasingly familiar in the world today. A joint 
study performed by the Dave Thomas Foundation and the Evan B. Donaldson Institute 
estimated that, in 2002, 64% of Americans had been exposed to adoption, either through 
their own families or through the experience of friends. With the increasing prevalence of 
adoption and favorable public perception of adoption, this number can be expected to 
increase (Dave Thomas Foundation for Adoption, 2002). 
According to the 2010 United States Census, two percent of the 64.8 million 
children under the age of eighteen in the United States are adopted, totaling 1.5 million 
adopted children (Kreider & Lofquist, 2010). However, this represents only a small 
portion of the adoptees living in the United States today, with many more over the age of 
18. Within the adoption process, several categories of adoptions exist: closed, open, and 
semi-open adoptions (Corder, 2012). In a closed adoption, the adoptee does not have 
contact with his or her birth family. Only through a search initiated by the adoptee can 
contact be achieved. Open adoptions allow the adoptee and the birth family to maintain 
contact using various methods such as letters. However, the amount of information 
exchanged can vary. Finally, semi-open adoptions permit the exchange of
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 some information between the adoptive family and the birth family, but this excludes 
identifying information, such as names.  
Overall, open adoptions are becoming increasingly common, but many current 
adult adoptees underwent closed adoptions (Kavanaugh & Fiorini, 2016; Corder, 2012). 
Even with open adoptions, however, a lack of information about biological family 
members can exist. For example, in one study performed by Hill and Edwards (2009) 
examining 57 adoptions, it was found that information was available for less than 50% of 
birth fathers, even when information about the birth mother was known (May et al., 
2015). In addition, for almost two-thirds of international adoptees, no written medical 
records exist. Therefore, a lack of family health history information is not uncommon 
among the adopted population, and this lack of genetic knowledge can serve as a factor 
driving adoptees to pursue genetic testing (Corder, 2012; Crouch et al., 2014; Hill & 
Edwards, 2009).  
1.3 Direct-to-Consumer Genetic Testing Overview 
Francis Collins, director of the National Human Genome Research Institute, 
stated in 2001 that “virtually every human illness has a hereditary component.” The U.S. 
Surgeon General initiated its Family History Public Health Initiative campaign in 2001 to 
promote conversation regarding family health history (Collins & McKusick, 2001; Rich, 
et al., 2004). Public knowledge and awareness of the role of genetics in health and 
disease continues to grow. In 2004, a survey performed by the Center for Disease Control 
(CDC) asked 4,000 participants about the role of family health history in personal health, 
and 96% of participants believed that family health history was important to one’s own 
health history (Centers for Disease Control and Prevention, 2005). This increased public 
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awareness of the contribution of genetics to health and disease, along with recent 
technological advances, could be one of the major driving forces for the growth and 
expansion for DTC-GT companies (Collins & McKusick, 2001). Several studies cite a 
desire to learn about personal disease risk and a curiosity about genes as major 
motivations for purchasing DTC-GT (Sanderson et al., 2015; Gollust et al., 2012; Su et 
al., 2011; Baptista et al., 2016). 
Traditionally, genetic testing has been ordered through a healthcare provider such 
as a genetic counselor or physician (What is Direct-to-Consumer Genetic Testing?). The 
healthcare provider collects a DNA sample and interprets the test results. DTC-GT, 
however, is a growing field that provides an opportunity for consumers to independently 
order genetic tests. These tests are marketed directly to consumers and eliminate the need 
to interact with a medical professional. The customer receives a testing kit in the mail, 
collects a DNA sample, and mails this kit back to the laboratory. The results are sent 
directly to the customer, usually through an online report.  
In 2008, Time magazine named such DTC-GT, or “The Retail DNA Test,” the 
Invention of the Year, and this market has continued to grow and develop over the past 
eight years (Hamilton, 2008). According to a meta-analysis by Phillips (2016), as of 
January 2016, approximately 246 companies provide some form of DNA testing that can 
be ordered online. The results of DTC-GT can offer a mixture of health information, 
carrier status for autosomal recessive conditions, ancestry composition, genetic 
relatedness, pharmacogenetic information, and much more. For example, 23andMe 
(Mountain View, CA), one of the leading companies in the DTC-GT field, now provides 
carrier status information for 41 conditions; ancestry reports; wellness reports for eight 
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characteristics; and reports for 22 traits that make individuals unique, such as sweet taste 
preference (www.23andme.com). The company celebrated its one-millionth customer in 
2015 (Turrini & Prainsack, 2016).  
Other companies choose to focus on one specific area. AncestryDNA, for 
example, provides its customers with information about their ethnicity and identifies 
possible relatives that have also used the site (dna.ancestry.com). The market for DTC-
GT companies continues to expand. The 23andMe test is now offered in 56 countries, and 
AncestryDNA, which first offered a genealogical DNA test in five countries in 2015, has 
now expanded to 29 additional countries (Harper, Kennett, & Reisel, 2016). 
In addition to sites such as 23andMe and AncestryDNA that directly provide 
genetic risk or ancestry information, DTC-GT customers have the opportunity to access 
and download their raw genetic data from these sites and then use third-party tools to 
further analyze the data (Kirkpatrick & Rashkin, 2016). These third-party tools include 
companies such as Promethease, GEDMatch, and Strategene, which utilize the raw data 
provided by DTC-GT companies to further extrapolate information that has the potential 
to impact medical management and provide more in-depth ancestry information 
(Kirkpatrick & Rashkin, 2016; http://seekinghealth.org/product/strategene). These types 
of tools allow customers to learn even more from the genetic information originally 
obtained from DTC-GT.  
1.4 United States’ Food and Drug Administration Crackdown on Direct-to-
Consumer Genetic Testing  
In 2013, the DTC-GT company 23andMe failed to provide data supporting the 
analytical and clinical validity of its testing methodology to the United States Food and 
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Drug Administration (FDA) (Nelson, 2016; Chung & Yim, 2014), in response to FDA’s 
concerns that consumers might be making medical decisions based on inaccurate 
information. Similar concerns were previously expressed by the American College of 
Medical Genetics (ACMG) in 2003, the American Society of Human Genetics (ASHG) 
in 2007, and other professionals in the field. FDA’s warning letter sent to 23andMe in 
November of 2013 warned the company that the saliva-based mechanism used for genetic 
testing would be considered a medical device under regulation, and therefore, further 
marketing approval would be required.  
On December 5, 2013, 23andMe ceased the production of all health-related 
genetic tests; after meeting FDA requirements, carrier status testing for 41 autosomal 
recessive conditions was resumed in October of 2015 (Nelson, 2016; Chung & Yim, 
2014; Stoeklé, Mamzer-Bruneel, Vogt & Hervé, 2016). This action taken by FDA 
towards 23andMe also impacted the development of past and current DTC-GT in terms 
of the amount and type of information shared with consumers (Chung & Yim, 2014). 
FDA continues to keep tabs on companies providing information from DTC-GT tests. In 
November 2015, for example, three companies marketing genetic testing with supposed 
clinical utility received warning letters from FDA for the use of technologies that had not 
received approval (Brunstein, 2016).  
1.5 Risks and Benefits of Direct-to-Consumer Genetic Testing 
Supporters of DTC-GT argue that it promotes patient autonomy and 
empowerment (Turrini & Prainsack, 2016; Bloss, Schork, & Topol, 2011). By supplying 
consumers with their genetic health information, DTC-GT can encourage healthier 
lifestyle choices (Bloss et al., 2011). Furthermore, proponents argue that this information 
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could also promote increased compliance with health screening practices. Patients can 
use of this form of more individualized genetic health information to adjust their health 
and lifestyle choices accordingly.  
Several concerns also surround the DTC-GT market. In addition to worries about 
test validity, there is the potential for adverse psychological effects of DTC-GT results 
reports (and customers’ interpretations of them). One reason for such a concern arose 
from the biased presentation of information on DTC-GT websites in which the listed 
benefits of such tests far outweighed the statements regarding risks and limitations 
(Singleton, Erby, Foisie, & Kaphingst, 2012). The worry is that consumers of DTC-GT 
are incapable of making a fully informed decision. If websites focus primarily on the 
advantages of DTC-GT, this results in a customer’s biased opinion regarding the impacts 
of the test. The customer has a false impression of the test’s benefits without being fully 
informed of its risks and constraints.  
However, most of the literature to date demonstrates that these worries are not 
supported by research. Many studies have demonstrated a less significant psychological 
impact than expected (Bloss et al., 2011; Eggelstone, Morris, & O’Brien, 2013; James, et 
al, 2011; Bloss, Wineinger, Darst, Schork, & Topol, 2013). In general, no significant 
difference in pre- and post-test level of anxiety was observed, even before FDA limited 
the genetic conditions for which this information could be reported. When participants 
did experience a change in anxiety level, anxiety was most often reduced. The majority of 
study participants experienced no rise in distress related to genetic testing after receiving 
results (Bloss et al., 2011; James et al., 2011). Overall, participants were likely to realize 
that health conditions are multifactorial in nature, and genetic testing results are not 
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deterministic. (James, et al., 2011). Therefore, regardless of marketing practices and the 
receipt of genetic test information that was anticipated to cause distress or anxiety, much 
of the research has shown that claims regarding the adverse psychological effects of 
DTC-GT are not supported.  
1.6 Risk Perception and the Role of Family History 
Risk communication can be described as “the open two-way exchange of 
information and opinion about risk, leading to better understanding and better (clinical) 
decisions,” (Ahl et al., 1993; Sivell et al., 2008). The manner in which individuals 
construct and understand genetic risk is a complex, multi-faceted process unique to each 
individual (Sivell et al., 2008). Risk perception can be impacted by cultural beliefs, 
personal experience, stress level, genetic or family history factors, and many other facets 
of information. It has been observed that family history along with other factors can alter 
risk perception. For example, an individual’s experience with illness in his or her family 
greatly impacts the way risk is viewed. This holds true in terms of DTC-GT as well. An 
individual’s family history likely impacts both how one views the magnitude of disease 
risk as well as the clinical actions taken after learning testing results. In fact, family 
history of disease can be used to predict actions taken in response to receiving DTC-GT 
results, for example changing medication, pursuing follow-up testing and screening, and 
changing diet (Kaufman, Bollinger, Dvoskin, & Scott, 2012). 
Furthermore, family history plays an important role in interpreting the results of 
such tests. Generally, a combination of genetic testing and family history is considered to 
be the optimal method of risk analysis when using DTC-GT (May et al., 2015). In a 
position statement on DTC-GT issued in February of 2016, the ACMG noted that 
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“medical interpretation of such results is often complex and includes patient specific 
information, such as prior medical and family history and other factors.” Ideally, genetic 
test results should be combined with family health history to provide to most effective 
and accurate risk assessment.  
1.7 Adoptees and Direct-to-Consumer Genetic Testing 
In an ideal world, every individual has access to complete family health history. 
In the real world, however, this is not always the case, especially for adoptees who often 
have little or no family health history. This lack of family history that exists for many 
adoptees can also be a driving force for pursuing DTC-GT (Corder, 2012; Crouch et al., 
2014; Hill & Edwards, 2009).  
Previous research has shown that motivations for the use of DTC-GT include 
curiosity about genetics, a desire to learn more about disease risk for one’s self and one’s 
family, interest in novel technology, a desire to improve health, self-exploration, and 
professional use (Gollust et al., 2012; Su, Howard, & Borry, 2011; Sanderson et al., 
2015; Baptista et al., 2016). Among these, a desire to learn more about disease risk and a 
curiosity about genes appear to be the most widespread motivations for customers of 
DTC-GT, and these are common among both adopted and non-adopted customers. 
However, adoptees are more strongly driven by a desire to learn about their genetic 
disease risk than non-adoptees, which may be due to the lack of family history that is 
prevalent in the adopted population (Corder, 2012; Crouch et al., 2014; Hill & Edwards, 
2009). The question of the unknown family history may impact adoptees in several 
aspects of their lives including mental health, the management and prevention of disease, 
and a feeling of stigmatization in medical settings due to the embarrassment that arises 
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from an inability to directly answers health professionals’ questions regarding family 
history.  
DTC-GT offers a unique opportunity for adoptees to unearth some of this elusive 
genetic information. However, adoptees may also have unrealistic expectations for DTC-
GT, and adoptees’ disappointment with the DTC-GT testing experience may in some 
cases stem from a lack of definitive information surrounding genetic risk (Baptista et al., 
2016). For some adoptees, DTC-GT may be the only avenue for obtaining family history 
information (May et al., 2015). This may lead to a higher set of expectations placed on 
testing results, and without access to a full family health history, the interpretation of 
such results may be complicated or unclear, resulting in frustration at the uncertainty 
(May et al., 2015; ACMG, 2003).  
1.8 Study Purpose and Goals 
The use of genetic counseling services after the return of results of DTC-GT is 
perceived to be both beneficial and informative (Darst, Madlensky, Schork, Topol, & 
Bloss, 2014). It is also known that interest within the adoption community exists for 
genetic counseling services (Bartiomioli, 2008). However, in both of these populations, 
use of genetic counseling services is rare. The reasons for this have not been fully 
explored, but the lack of use of genetic counselors within the adopted community may be 
due to a lack of awareness, a fear of an inability to provide adequate genetic information, 
deterrence due to perceived medical stigmatization, or a combination of these factors 
(Baptista et al., 2016; Hill & Edwards, 2009).   
Limited research has been done focusing on adoptees in the context of DTC-GT, 
and even less qualitative research has been done in this area. Through one-on-one 
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interviews with adult adoptees who have undergone the DTC-GT experience, this study 
aimed to evaluate adoptees’ motivations for pursuing genetic information, their 
satisfaction with the test results from DTC-GT, their questions that remain unanswered, 
their emotions throughout the process, and their interest in discussing this information 
with genetic professionals, specifically genetic counselors. This was primarily an 
exploratory study. The goal of this study was to provide insight into a population that 
might benefit from meeting with genetic counselors and to highlight unique areas of 
concern or interest. By making an effort to understand the needs of this patient 
population, genetic professionals may be able to address specific concerns and clarify 
both the power and the limitations of DTC-GT. With the population of adult adoptees 
growing along with the use of DTC-GT, this presents a unique niche for genetic 
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Public awareness of the role of genetics in disease continues to expand, along 
with the use of DTC-GT. One subset of customers taking advantage of the growing DTC-
GT market is adoptees. Prior research has shown that adoptees appear to be more 
motivated than non-adoptees to learn about their genetic disease risk but have similar 
responses to health-related information acquired through DTC-GT. In this exploratory 
qualitative study, fourteen adoptees were asked about their motivations for pursuing 
DTC-GT; satisfaction with results; emotions throughout the process; and interest in 
meeting with a genetic counselor. Motivations for pursuing DTC-GT fell into three 
categories: 1) identity-seeking, 2) a desire for health information, and 3) general 
curiosity. Adoptees reported a variety of emotional responses to DTC-GT but had more 
profound emotional reactions to ancestral information, related to both ethnicity and 
biological familial connections. Finally, the majority of adoptees found value in meeting 
with a genetic counselor, either for themselves or for their family given certain 
circumstances. Overall, this study highlights adoptees’ experiences in their pursuit of 
genetic information. By understanding this population’s journey with genetic testing, 
genetic counselors and genetics professionals can be better equipped to address the 
concerns and emotions of this population that is receptive to the idea of genetic 
counseling. 
2.2 Introduction 
Adoption is considered to be a “legal process in which a child is raised by 
someone other than his or her biological parents,” and it is an idea that is familiar to the
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majority of Americans (Kavanaugh & Fiorini, 2016; Corder, 2012; Dave Thomas 
Foundation for Adoption, 2002). Unfortunately, among adopted individuals, a lack of 
knowledge regarding family medical history is common (May et al., 2015; Hill & 
Edwards, 2009).  
Additionally, DTC-GT is a growing market in which customers have the 
opportunity to order genetic testing without the involvement of a medical professional 
(Phillips, 2016; Harper et al., 2016). These genetic tests offer information regarding a 
variety of topics, including health information, carrier status for autosomal recessive 
conditions, ancestry, and genetic relationships (Phillips, 2016). Common motivations for 
pursuing DTC-GT include the desire to learn more about the risk of disease and an 
interest in genes; when compared to non-adoptees, adoptees that have undergone DTC-
GT appear to be more strongly motivated by the possibility of learning about genetic 
disease risk (Gollust et al., 2012; Su, Howard, & Borry, 2011; Sanderson et al., 2015; 
Baptista et al., 2016). This could in part be due to the lack of family health history that is 
widespread in the adopted population (Corder, 2012; Crouch et al., 2014; Hill & 
Edwards, 2009).  
The genetic contribution to disease is becoming increasingly recognized, and 
family medical history is known to be an important factor in the analysis of disease risk 
assessment (Collins & McKusick, 2001; Rich et al., 2004; Centers for Disease Control 
and Prevention, 2005). For adoptees with a lack of complete family medical history, 
genetic risk assessment, even with the use of DTC-GT results, can be unclear and 
uninformative (May et al., 2015; ACMG, 2016).   
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This study aimed to gain a more in-depth understanding of adoptees’ experiences 
with DTC-GT. Through semi-structured interviews with adoptees that have gone through 
the DTC-GT experience, this study aimed to evaluate several key topics: 1) adoptees’ 
motivations for pursuing genetic information, 2) adoptees’ satisfaction with DTC-GT 
results, 3) adoptees’ remaining questions after DTC-GT, 4) adoptees’ emotions 
throughout the DTC-GT process, and 5) adoptees’ interest in discussing this information 
with genetic professionals, specifically genetic counselors. Because little qualitative 
research exists analyzing adoptees’ use of DTC-GT, this was primarily an exploratory 
study with the goal of providing insight into a specific population’s experience with 
DTC-GT. The hope is that genetic professionals may use this information to better 
understand adoptees’ areas of concern and interest when discussing genetic information 
and that the results may also be used to delineate a unique niche for genetic counselors 
within the world of DTC-GT (Dave Thomas Foundation for Adoption, 2002; Harper et 
al., 2016).  
2.3 Materials & Methods 
2.3.1 Participants and Recruitment. This study targeted adult adoptees who 
have used DTC-GT. Eligible participants included adopted individuals over the age of 18 
who had purchased DTC-GT and received testing results. Additionally, eligible 
participants were required to have used either a DTC-GT website that supplies health-
related information (ex. 23andMe) or a third party tool that shares health-related 
information (ex. Promethease or StrateGene). Only English-speaking participants were 
included in this study. Interpretation from English to other languages was not available 
due to limited resources. 
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Individuals were invited to participate through a study advertisement, shown in 
Appendix A, posted on Facebook, Twitter, and the 23andMe online discussion forum for 
adoptees. This advertisement provided a link to a description of the study and a brief 
questionnaire (Appendix B) on SurveyMonkey. This study description also provided 
contact information for the investigators. Interested individuals answered questions 
regarding demographic information, expressed or declined interest in a telephone 
interview, and provided contact information that could be used to schedule the interview.  
2.3.2 Study Methods. Ethical approval for this study was obtained from the 
University of South Carolina Institutional Review Board.  
Semi-structured interviews were conducted with 15 adoptees’ that purchased 
DTC-GT. Interested participants were first required to complete a short, web-based 
questionnaire on SurveyMonkey to acquire demographic information and determine 
eligibility. By beginning the questionnaire, participants gave their consent. Eligible 
participants who agreed to participate in the interview and provided contact information 
were then contacted by the principal investigator (AC) through telephone or email 
(whichever method of contact was listed as preferred) to schedule the interview. If a 
participant was not reached after two attempts, no further effort was made.  
The interviews were conducted by AC over the telephone. Participants had the 
ability to choose not to respond to a question or to end their participation in the study at 
any time without penalty. The interviews were recorded, with permission of the 
interviewee, and transcribed verbatim. Audio files were stored on a password-protected 
computer. Aside from contact information used to schedule and perform the telephone 
interviews, no identifying information was obtained from study participants. This 
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information was also stored on a password-protected computer and destroyed after the 
completion of the study.  
2.3.3 Study Measures. Demographic information was collected from each 
participant, including data regarding age, gender, race, level of education, age at 
adoption, DTC-GT companies used, and the date of genetic testing. The semi-structured 
interview consisted of 13 questions designed to explore the various goals of the study. 
These questions can be found in Appendix C. While on the phone, participants were also 
asked to confirm the DTC-GT companies or third-party tools used and the date of the 
testing.  
2.3.4 Data Analysis. Descriptive statistics were used to analyze demographic 
information and to determine frequencies and averages. This study used a qualitative 
methodology to assess adoptees’ motivations for pursuing DTC-GT, determine adoptees’ 
satisfaction with DTC-GT results, provide insight into adoptees’ emotional responses to 
DTC-GT, and assess adoptees’ interest in sharing this information with genetic 
counselors. Grounded theory methodology was used to code and distinguish emergent 
themes (Hsieh & Shannon, 2005; Bradley, Curry, & Devers, 2007). Data was 
independently coded by AC and co-investigator, WD, with consistent inter-coder 
reliability checks and discussion of discrepancies.  
2.4 Results 
2.4.1 Participants. A total of 37 individuals completed the web-based 
questionnaire. Of these, three were not eligible to participate in a telephone interview: 
one was not adopted; one had not received her DTC-GT results; and one was under the 
age of eighteen. Of the remaining 34 individuals, five specified that they were not 
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interested in participating in an interview over the phone. Therefore, 29 individuals were 
contacted in an attempt to schedule a telephone interview. Fifteen adoptees responded 
and were interviewed over the phone, yielding a response rate of 51.7%. However, due to 
a technical error, one interview was not recorded and not included in the results. 
 The age of participants ranged from 40-64 years old with an average age of 50.5 
years. The majority of participants were Caucasian (71.43%) and female (85.71%). In 
addition, most had completed some level of college or university education (57.14%) or 
had received a bachelor’s degree (35.71%). Although the age at the time of adoption 
ranged from birth to seven years, the majority of the adoptees were adopted before the 
age of one year (66.7%). Complete demographic details are in Table 2.1 (page 34). 
2.4.2 DTC-GT Tools Used. A total of nine DTC-GT companies and tools were 
used, with 23andMe (85.71%) and AncestryDNA (78.57%) being the most frequently 
reported. The majority of participants used more than one website (85.71%), and half of 
the participants used three or more websites (Table 2.2, page 34).  
2.4.3 Motivations. In exploring adoptees’ motivations for pursuing DTC-GT, 
three main motivating factors emerged: 1) the search for some form of identity, 2) the 
desire for health-related information, and 3) general curiosity.  
The idea of seeking some form of an identity surfaced throughout the majority 
(64.29%) of adoptees’ stories. However, the method through which this self-actualization 
was achieved was further divided into two categories: the search for biological family 
and the search for ethnicity and nationality.  Adoptees saw DTC-GT as a way to identify 
biological family that was previously unknown or unconfirmed, and for many, this was 
the first opportunity to learn such information. For example, one adoptee noted that “you 
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know nothing your whole life…your blood line starts and ends with you…” DTC-GT 
offered the possibility of becoming part of a larger, family unit. A different adoptee 
described this genetic testing as bringing “into perspective that you do have, like, blood 
relation out there that you belong to…” 
 For other adoptees, this feeling of completion was achieved through learning or 
confirming their ethnicity or nationality, and this was their means of creating an identity. 
Again, learning this information offered the potential to consider one’s self as part of a 
group and form those connections with one’s past. One adoptee described it as the 
opportunity to “learn” and “connect.” She elaborated on this sentiment, saying the 
following: 
“People are proud of their heritage, and all your whole life you don’t 
have one…You’ve had no family so a nice diverse one to me was being 
able to go ‘oh gee I can associate with that, associate with that, associate 
with that, find out about all those different cultures...’” 
Five adoptees (35.71%) planned on using the DTC-GT results for their own 
medical care and saw it as a way to gain information about their own risk. An adoptee 
experiencing vision loss, for example, noted that “as you get older, you have more health 
concerns,” and she “wanted to find out possibly if [she] could find out [her] biologic 
family in order to kind of come to terms with this vision issue.” Another adoptee 
described this as a way to “look out for [her]self, to say hey, [I] might want to choose this 
diet or this habit.” 
Five other participants (35.71%) wanted to acquire this information for their 
family, whether it be children or grandchildren, in the hopes that it might improve the 
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care of their family members. One adoptee explained that “if it was just for me, I 
probably wouldn’t have done it, but I did it so my kids would have some kind of answer.”  
Another echoed this sentiment, saying that “[she] thought it would be nicer for [her] 
children and grandchildren maybe not to have to go through all of that,” in reference to 
the additional medical tests that she had to undergo due to her unknown family history. 
Finally, a third adoptee with a sick son described her desire for genetic information as 
“not a need to assess blame, but a need to figure it out.” 
Three adoptees (21.43%) cited general curiosity as a major push for them 
pursuing DTC-GT. There were no clear goals in mind and there was nothing they were 
hoping to learn. Rather, any bit of knowledge was viewed as something of value simply 
because they started with such little information. For example, one adoptee stated that 
“you have so little information as an adoptee, really, that any shred of information, 
anything, is such a wonderful gift.” 
 2.4.4 Satisfaction. Adoptees expressed mixed levels of satisfaction with their 
DTC-GT. The majority of participants (57.14%) answered that they were satisfied with 
all the testing results that they received. Six adoptees (42.86%) made connections with 
their family or learned about various biological relationships. For example, one adoptee 
who was able to identify her birth father’s family expressed her happiness, saying, “So I 
count myself pretty lucky that without basically any information I was able to find my 
birth father’s family through DNA testing.” The few adoptees that were satisfied, but did 
not find immediate connections, were still pleased with any information, and in the words 
of one adoptee, felt that this information was helpful in “aiming [them] towards the right 
direction” in the search for more information. 
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However, five of the remaining participants (35.71%) had mixed feelings 
depending on the testing company and the information provided by the test. The reasons 
for dissatisfaction all stemmed from one major theme: a desire for more information. This 
need for more information was grouped into two categories: 1) frustration with the lack 
of familial information, in terms of matches and family history and 2) a desire for more 
specific medical and genetic risk information.  
For two adoptees, frustration arose from a lack of response from biological family 
members. One described her anger with her biological family’s silence, saying that this 
made her feel as though she was “still some family’s dirty little secret that they don’t 
want to talk about.” Two other adoptees cited a lack of close familial matches that caused 
frustration. For example, one of these that planned to use her familial matches to acquire 
medical information said that “[she] was hoping to be able to get someone close enough 
to, at the very least, get that medical information.” The other’s lack of close matches 
resulted in feelings of “disappointment.” Finally, two of the adoptees also noted that it 
would have been nice to know the origin (maternal or paternal) of the genetic information 
they received.  
 Five of the adoptees also noted that the health-related information that they 
received was not what they had hoped. Several desired more, and several also desired 
more actionable information. Specifically, one adoptee stated that “[she] wish[es] [the 
test] could be more definite” and “a little more clear.” Another explained that “if [she] 
had been someone who wanted to use [the DTC-GT] information instead of going to a 
doctor, [she] probably would’ve been dissatisfied because it’s pretty vague.” 
 
22 
 2.4.5 Interest in Genetic Counseling. When asked if they saw value in meeting 
with a genetic counselor, the majority of adoptees (85.71%) responded that they did see 
benefits to genetic counseling. Their reasoning and the circumstances under which they 
would pursue genetic counseling were grouped into four categories: 1) adoptees saw this 
access to genetic information as valuable, 2) adoptees believed that this would have been 
useful when they were younger, 3) adoptees saw merit in it for their family members, and 
4) adoptees would have pursued genetic counseling if a medical concern arose.   
 Twelve of the adoptees saw genetic counseling as a useful and valuable tool. One 
adoptee expressed her interest in genetic counseling, saying “I feel strongly if there’s a 
way to test for things and if there’s a way to counsel people on how to deal with things, I 
think you should.” Another was thinking that the information provided by a genetic 
counselor could help to “ease some questions.” 
Those who thought that this information could have been useful in the past 
(21.43%) acknowledged that they were no longer focused on genetic risk information, 
either because they were finished having children or had already faced several health 
concerns. One adoptee described her health situation:  
“I think I would have been very interested…about maybe about five years 
ago when all of my vision issues occurred. But at this point…I don’t want 
to because I’m dealing with this vision issue now. And whatever 
happens…I’ve been so fraught with worry about the vision issue that 
anything else I get, I’m not even worried about it." 
Three adoptees (21.43%) noted that genetic counseling might be of use for their 
family members, especially their children or those that have children. For example, one 
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adoptee thought of her son, saying she would “definitely recommend it to him” if he 
decides to have children, and another thought that genetic counseling would have been 
useful for her sister who has children 
Finally, six adoptees noted that in the event that their test results came back 
saying they were a carrier of a certain genetic condition or if a new medical concern 
arose, they would have been willing to meet with a genetic counselor to gain more 
information. Overall, adoptees were open and receptive towards the idea of meeting with 
a genetic counselor. However, for the two adoptees that did not see value in meeting with 
a genetic counselor, this was due to their own knowledge in the field. For example, one 
adoptee did not see any value in genetic counseling for herself because she has “a good 
enough basic understanding of all the components that cause and further a disease 
process.”  
2.4.6 Emotions. Adoptees reported a variety of emotional responses to the 
process of undergoing DTC-GT (Figure 2.1 and Figure 2.2, page 35 and 36). In general, 
emotions experienced before receiving DTC-GT results fell into three categories: 1) 
excitement, 2) anxiety and a fear of the unknown, and 3) a fear of rejection.  
Eleven adoptees (78.57%) were excited at the possibility of learning new 
information about their biological family, their ethnicity and nationality, and their various 
medical traits. A few adoptees were also excited at confirming the little information that 
they already had, whether it be information regarding familial relationships or 
information regarding ethnicity and nationality. One adoptee described her excitement at 
the possibility of matching with a close relative and said that she “kind of daydreamed 
24 
about maybe going and meeting people.” Another said that while waiting for the results, 
“[she] [was] almost like a kid on Christmas morning waiting for that day.” 
Anxiety corresponded with a fear of the unknown for five of the adoptees 
(35.71%). These adoptees recognized that having no information on their background 
meant that they had no way of knowing what DTC-GT might reveal, and this created the 
feelings of anxiety. One adoptee compared this process to opening “Pandora’s box,” 
saying that it required “soul-searching” before sending off the testing kit. Another 
described feelings of excitement and fear before testing because “even though [she] 
desperately wanted the answers, [she] [didn’t] know what the answers [were].” She was 
worried that the DTC-GT results “might make [her] think of [her]self in a different way.” 
Finally, a feeling experienced by three adoptees (21.42%) prior to undergoing 
DTC-GT was a fear of rejection on the part of their biological family. One adoptee 
recognized that DTC-GT offered the possibility of finding biological family, and this 
brought into question, “are they going to accept me, or are they going to reject me 
again?” Another adoptee elaborated on this sentiment:  
“One of the innate issues of being adopted is being rejected and having 
that glooming rejection over you for your whole life. So many adopted 
people, I think, don’t even bother to reach out and try because they’re just 
afraid that they’re going to be rejected again. So I think once they get to a 
point where they think the reward will be worth more to them than that 
fear is when they decide to try and seek those answers.” 
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The emotions experienced after DTC-GT were grouped into four main categories: 
1) obsession with new connections, 2) a feeling of a newfound direction in the search for 
more information, 3) frustration and disappointment, and 4) happiness.  
Four adoptees (28.57%) experienced a compulsion to continuously check the 
familial matches portion of their test results, explaining that this was ever-changing as 
more and more people were doing these tests. They described this portion of their test as 
a newfound obsession, hoping to discover more and closer familial matches. One adoptee 
stated that after receiving close familial matches, she experienced this “obsession,” and 
she wanted “to just spend all of [her] time looking at these people and trying to figure out 
how [she] [was] related to them.”  
However, five adoptees (35.71%) also noted that this obsession over checking for 
new connections, and this information in general, provided a new sense of direction in 
their search for familial information. One adoptee described this process as putting a 
“method to the madness.” Another described herself as being “positive and gung-ho” 
because she “knew what direction to look and then [she] started having things to work 
with that could get [her] further.” A third adoptee considered herself to be a “detective” 
saying that “everything from that point on, every single step [she] took on this path was 
more information.” 
Three adoptees (21.43%) noted that they did not receive close familial matches or 
were not given much information from their biological family when they did attempt to 
make contact. These circumstances led to feelings of frustration and disappointment. For 
example, one adoptee said that she was both angry and disappointed because she had 
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been met with “complete silence” from her biological family after attempting to create 
connections.  
 Overall, the majority of adoptees (51.74%) were happy with the results that they 
received. Several viewed any information as more than what they knew originally. One 
adoptee stated the she was “really grateful to finally know [her nationality] for sure rather 
than guessing.” Many adoptees were able to connect with their biological family. There 
were adoptees that learned valuable health information from the DTC-GT, such as an 
adoptee that stated that the “little $99 probably saved [her] life.” Through DTC-GT, she 
was made aware of a rare form of hemophilia that she had and considered the genetic 
testing “the best thing that ever happened.” Others were put at ease after learning that 
they had no genetic susceptibility for the tested conditions. All of these circumstances led 
to overall feelings of happiness in adoptees regarding DTC-GT. For example, one 
adoptee described herself as being “just happy” after DTC-GT, saying that she felt like 
she had “a piece of the puzzle.” 
 2.4.7 Adoptees Versus Non-Adoptees and DTC-GT. When asked how adoptees 
might view the DTC-GT differently than non-adoptees, the main theme that adoptees 
highlighted was a difference in motivations for pursuing the testing. More specifically, 
adoptees emphasized that this form of testing was, for many, their only source of genetic 
information rather than a way to satisfy general curiosity about one’s family or 
background. One adoptee summarized this sentiment, saying, “I’m not looking because 
I’m curious about my family. I’m looking for my family, and that’s a huge difference.” 
Another described DTC-GT for adoptees saying that “for someone who’s adopted, 
there’s a whole other layer of it…I could find my biological family by doing this.”  
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 Within this theme of different motivations, five adoptees (35.71%) also explained 
that for them, this information filled a void that those with knowledge of their family and 
genetic makeup might not have had. The potential of gaining biological family or a 
nationality changed their perspective of themselves. One adoptee stated that learning 
about biological connections “[made] you feel like you belong.” Even the health 
information offered some adoptees a feeling of comfort, knowing which conditions or 
traits should concern them.  
 2.4.8 Adoptees’ Experiences in Medical Settings. The majority of adoptees 
(71.43%) answered that they do believe that being adopted has affected their medical care 
and their interaction with medical professionals. The overarching themes of adoptees’ 
answers as to how their experiences in medical settings might be different fell into three 
categories: 1) changes in medical care, 2) feelings of marginalization and stigmatization, 
and 3) feelings of frustration.  
 Three adoptees (21.43%) acknowledged that not knowing their family history of 
certain conditions led to earlier screening and testing for many conditions, either for the 
purpose of having a baseline available or due to not knowing the actual genetic risk for a 
condition. These adoptees noted that this has a huge cost in time, effort, and money when 
in fact, this might not have been necessary. One adoptee described it as a lot of “time, 
effort, and unknown.” A statement from a second adoptee echoes this sentiment:  
"It’s a thing where you kind of know what to expect if you have a family 
[history of] say breast cancer or heart disease. You can start looking early 
at those things so you can do preventative measures. You can’t do any of 
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that when you have none of that information. Right? You’re stuck doing it 
all…. The doctors have to assume you’re high risk for everything." 
Five adoptees (35.71%) also described experiences that fit under the themes of 
marginalization and stigmatization. These were brought about by several factors. First, 
adoptees noted the medical paperwork that patients were required to fill out prior to a 
visit. In general, adoptees felt as though their status of being adopted was not viewed as a 
valid status for an individual. For example, one adoptee explained that the medical 
establishment does not “tend to take adoption as an equally weighted option,” and she has 
only encountered one intake form that has listed adopted as an option. In addition, 
adoptees described feelings of stigmatization brought about by the reactions of medical 
professionals upon learning that they were adopted. One adoptee, for example, described 
walking out of doctors’ offices because the doctor wrote “in big red letters across the 
folder ‘adopted.’” She described this as “horrific” and felt as though the doctor “acted 
like it was leprosy.” Another adoptee described the conversations that she has had with 
medical professionals that impacted her experience: 
"You know, and they backtrack like at a hundred miles per hour… because 
they really want to know does this run in your family, and they’re talking 
to a patient that says I have no information. And they’ll go like oh crap, 
okay, no it doesn’t matter, and you know that’s not the truth. So there’s 
like this game playing even with your medical provider. It’s weird." 
 Finally, two adoptees (14.29%) noted that medical settings served as a constant 
reminder of their adoption. One adoptee compared going to the doctor to having “skinned 
knees, and every time you go in, they rip the scab off,” saying that she was “constantly 
29 
reminded that [she was] different.” Having to constantly specify that they were adopted, 
for some adoptees, brought about feelings of frustration. For example, the second adoptee 
described that “you grow up your whole life just saying don’t know, don’t know, don’t 
know, which is really frustrating.”  
 There were also four adoptees (28.57%) that did not believe that this changed 
their experience in medical settings, explaining that they saw it as very matter of fact. 
They did not know their family’s medical history, but they were indifferent to this. One 
adoptee said that “it’s not, never was, and still isn’t a sensitive subject to me.” 
2.5 Discussion  
This study sought to explore adoptees’ experiences with DTC-GT. Adoptees’ use 
of DTC-GT was strongly motivated by the need to create an identity, based upon 
ethnicity or biological familial information, and a desire for health-related information. 
Adoptees were noted to have strong emotional responses to DTC-GT results, most often 
in regards to newfound ancestral information. This qualitative insight might help genetic 
counselors and other genetic professionals to better understand and anticipate adoptees’ 
needs and responses to DTC-GT. This is an important factor to consider because adoptees 
were also found to be receptive to the idea of genetic counseling, and most saw value in 
such services. Therefore, this information can be helpful in equipping genetic counselors 
with the skills necessary for interacting with a target population that is interested in the 
profession. With the increasing popularity of DTC-GT, this might offer a unique niche 
for genetic counselors in the future.  
 Prior research has attempted to describe the general population’s motivations for 
pursuing DTC-GT (Gollust et al., 2012; Su et al., 2011). Gollust et al. (2012) found that 
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the most frequently reported motivations for pursing testing included a curiosity about 
genetics, a desire to learn about disease risk, and a desire to improve one’s health. Su, 
Howard, & Borry (2011) conducted an exploratory study analyzing internet posts written 
DTC-GT customers and found that personal health was most often cited. Baptista et al. 
(2016) specifically explored the motivations of adoptees that have undergone DTC-GT. 
In this study, adoptees’ motivations were similar to those in the general population, but 
adoptees were noted to be more strongly driven by a desire to learn about genetic disease 
risk. The majority found value in their results and were satisfied. However, a minority of  
adoptees were disappointed and expected more definitive genetic risk information, 
possibly due to unrealistic expectations for DTC-GT. The psychological impact of DTC-
GT has also been studied in the general population. Studies found that the impact was 
less significant than expected. Anxiety was often reduced (Bloss et al., 2011; Egglestone 
et al., 2013), and test-related distress typically did not increase after receiving results 
(Bloss et al., 2011; James et al., 2011). Therefore, although studies have been done that 
analyzed the motivations, emotions, and satisfaction of those that have undergone DTC-
GT, little research has been done exploring all of these factors specifically in adoptees, 
and furthermore, little qualitative insight is available for this population’s experience with 
DTC-GT.  
 This study generally supported the findings of previous studies in regards to 
motivations for pursuing DTC-GT (curiosity about genetics, a desire to learn about 
disease risk, and a desire to improve one’s health) but also highlighted another strong 
motivation for adoptees. Adoptees in this study most frequently cited three driving 
factors for purchasing DTC-GT: a desire to create some form of an identity, either 
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through ancestral or familial information; a desire to learn genetic health information; and 
general curiosity. Adoptees were strongly and almost equally driven by a need for health-
related information and ancestral information, encompassing familial relationships and 
ethnicity, and considered both sets of information to be extremely valuable. Su et. al 
(2011) included genealogical interest as a driver for purchasing DTC-GT in the general 
population, but this was not the most frequently cited motivator for this group. In this 
study, this was the most popular response, highlighting a possible distinction between the 
motivations of adoptees using DTC-GT and the motivations of the non-adoptees using 
DTC-GT. Adoptees themselves also cited this difference in motivations for pursuing 
DTC-GT, recognizing the test as a starting point for adoptees in gathering information 
rather than a way to confirm previous knowledge or satisfy a curiosity to know more.  
The emotional journeys of the adoptees interviewed in this study tend to support 
previous findings in the general population. For the minority of adoptees that did 
experience feelings similar to distress, however, these were related to ancestral 
information rather than the health portion of the test. This newfound information, whether 
it was discovering biological relationships or uncovering new information about 
ethnicity, was the most frequently discussed and seemed to have more of a profound 
impact than any health-related information. Therefore, although many adoptees’ 
emotional responses to DTC-GT were similar to those of the general population, this 
study highlighted distress-related responses that were more unique to adoptees and, 
perhaps, to others with limited family history.  With this information, we can anticipate 
that adoptees’ response to ancestral information might be the most emotional rather than 
any information regarding carrier status. Much like Baptista et al. (2016), adoptees in this 
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study cited a desire for more clear-cut genetic risks and more medical information. In 
addition, adoptees described frustration with a lack of close familial matches and a lack 
of response from biological family members. Together, these factors support the idea that 
adoptees might have unrealistic expectations for DTC-GT, but it offers insight into the 
fact that these expectations encompass both health and ancestry information. Being aware 
of these expectations has the potential to aid genetic counselors and other genetic 
professionals in providing anticipatory guidance before DTC-GT or in addressing these 
feelings of frustration after testing.  
This study found that, despite limited family history knowledge, the majority of 
adoptees saw value in genetic counseling services. This is promising for a field that is 
trained in addressing both the impact of genetic information on health care and the lack 
of genetic information on health care. This lack of information is not uncommon, and 
genetic counselors are trained to provide a detailed, yet sensitive, risk assessment. It is 
the hope that by understanding the desires, concerns, and expectations of this specific 
population, genetic counselors can shape their counseling to provide better care. 
Understanding adoptees’ anxiety and fear of the unknown, for example, allows genetic 
counselors to address this before DTC-GT, and knowing that adoptees might have high 
expectations for DTC-GT gives genetic counselors the opportunity to explain fully the 
limitations of such testing. This study also offered insight into how adoptees think that 
being adopted has negatively impacted their experience in medical settings. This provides 
medical professionals, such as genetic counselors, with the opportunity to adjust their 
actions and ensure that adoptees will no longer have these feelings of stigmatization and 
marginalization. Also, the genetic professionals working for DTC-GT companies can use 
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this information to change marketing in an attempt to eliminate some of these concerns 
upfront. This will help to ensure that this population remains receptive towards the 
services offered by genetic counselors and other genetic professionals.  
 The findings of this study complemented the existing literature examining 
adoptees’ experiences with DTC-GT but provided novel, qualitative insight into the 
emotional journey of adoptees going through this process. These findings provided 
insight into adoptees’ frustration with DTC-GT and offer more general information 
regarding adoptees’ experiences in medical settings. Future research could focus on the 
impact of genetic information on the family unit as a whole since adoptees’ children and 
grandchildren are also affected by this lack of family history information.  
 There were several limitations to this study. First, the participants as a whole were 
relatively homogenous in terms of race, gender, and educational background, and these 
results are not generalizable to adoptees as a whole. Most of the participants completed, 
at minimum, some level of college or university, and this might also impact their 
understanding and their opinion of genetic information. Finally, the method of 
recruitment limits generalizability. By advertising on forums and social media pages 
directed at adoptees, this targeted adoptees actively pursing information on adoptees and 
DTC-GT. These participants might have a greater interest in this information and might 




Table 2.1 Patient Demographics 
 
 n (Total = 
14) 




  50.5 + 6.37 
(40-64) 
18-29 0 0  
30-39 0 0  
40-49 7 50  
50-59 6 42.9  
60-69 1 7.1  
Gender    
Male 2 14.3  
Female 12 85.7  
Race    
Caucasian 10 71.4  
Native Hawaiian/Pacific Islander 1 7.1  
Mixed 2 14.3  
Other 1 7.1  
Educational Background     
Some high school 0 0  
High school diploma/GED 0 0  
Some college/university  8 57.1  
Bachelor’s degree 5 35.7  
Master’s/doctoral/professional 
degree 
1 7.1  
Age at Adoption (years)    
< 1   10 71.4  
> 1  4 28.6  
 
Table 2.2 Companies and Tools Used to Acquire Genetic Information  
 
 n (Total sample = 14) %* 
23andMe 12 85.7 
AncestryDNA 11 78.6 
Promethease 5 35.7 
GEDmatch 5 35.7 
FamilyTreeDNA 5 35.7 
StrataGene 1 7.1 
Genetic Genie 1 7.1 
MyHeritage 1 7.1 
DNA.land 1 7.1 
*Proportions do not sum to 100% because participants could report using more than one 
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Chapter 3. Conclusion 
 In this study, adoptees’ experiences with DTC-GT mirrored those of the general 
population in certain aspects. Many of the adoptees were interested in learning more 
about their genetic disease risk, similar to non-adoptees. However, interest in ancestral 
information regarding both familial relationships and ethnicity served as the motivating 
factor for over half of the adoptees in this study. Adoptees experienced strong emotional 
reactions to this ancestral information, perhaps setting them apart from individuals that 
already know their family history. Knowing the value that adoptees place on this 
information and understanding the potential for strong emotional responses can aid 
genetic counselors in providing both anticipatory guidance and post-test counseling to 
adoptees using DTC-GT.  
 The overwhelming majority of adoptees in this study saw a potential benefit in 
speaking with a genetic counselor, either for themselves of their family members, but the 
majority had also experienced feelings of stigmatization or marginalization in medical 
settings and attributed these to their status as an adoptee. Understanding these negative 
experiences can help genetic counselors to ensure that adoptees remain open to the the 
field and ensure that adoptees have positive experiences. Genetic counselors are well-
equipped to deal with patients with limited family history knowledge and are capable of 
providing information on how this impacts healthcare in a detailed, thorough, and 
sensitive manner.  
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 The DTC-GT market continues to grow and can serve as a primary source of 
information for many adoptees searching for both health and ancestral information. 
However, having an unknown family history can have an impact on how this information 
is interpreted and processed. Genetic counselors have the skills and training to help 
adoptees process the health-related genetic information and the reactions brought about 
by the ancestral information. Genetic counselors can provide adoptees with genetic risk 
information and tools to cope emotionally as well, providing a unique niche for genetic 
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Appendix A: Study Advertisement 
ADOPTEES THAT HAVE USED DIRECT-TO-CONSUMER GENETIC TESTING: 
Participants Needed! 
 
You are invited to participate in a graduate research study. We are interested in 
discussing the emotions that you experienced both before and after your genetic testing, 
your satisfaction with the test, and the desired outcomes that you had or still have for the 
test.  
Any person that is both legally adopted and over the age of eighteen qualifies for this 
study.  
 















Appendix B: Web-based Questionnaire 
 Through interviews with adoptees that have used direct-to-consumer genetic 
testing sites (maybe insert specific site here instead of “DTC-GT”, ex. 23andMe), this 
study hopes to learn more about adoptees’ motivations for using this type of genetic test. 
Adoptees will be asked about their feelings after having their test results returned and 
what they think about using these results in the future. Overall, this study hopes to 
provide insight into adoptees’ feeling about genetic information and whether or not they 
hope to use this in future medical settings. 
  If at any point you do not wish to answer a question, please skip that question and 
continue to the next question. This is a graduate student project being completed by a 
genetic counseling student at the University of South Carolina. For any questions please 
contact: 
Anna Childers     Whitney Dobek 
childersak09@gmail.com   whiney.dobek@uscmed.sc.edu 
  
1) Current Age: _____ 
 
2) Gender: ____ 
 
3) Race: 
o Alaska Native 
o American Indian 
o Asian 
o Black 
o Native American 




o Do not wish to specify 
 
4) Level of Education:  
o Some high school 
o High school diploma/GED 
o Some college/university 
o Bachelor’s degree 
o Master’s/Doctoral/professional degree  
 
5) Age at adoption: ____ 
 
46 
6) Genetic testing company used: __________ 
 
7) Date test results were received (MM/YYYY): _________ 
 
8) This study includes an interview conducted via phone call that may last up to one 




9) Please provide your preferred contact information so that we may contact you to set 
up the interview for this study. Your contact information will not way be linked to 























Appendix C: Semi-Structured Interview Questions 
 
1) How much do you know about your biological family?  
 
2) Do you have any children? If so how many?  
 
3) What was/were your main motivations for using DTC-GT?  
 
4) How would you describe your satisfaction with your test results? 
 
5) What information would you like to know more about? 
 
6) As someone who is adopted, how do you think you view this genetic information 
differently than someone who is not adopted?  
 
7) What kinds of feelings did you have before ordering this test? 
 
8) What kinds of feelings did you have while you were waiting for your test results to 
come back?  
 
9) How did these feelings change immediately after receiving your test results?  
 
10) What kinds of changes did you experience in these feelings 3 months after receiving 
your results? 
 
11) How does being adopted change your experience in medical settings? 
 
12) Do you know what a genetic counselor does?  
 
13) What value would you see in meeting with a genetic counselor either to discuss these 





Appendix D: Description of Adoptees’ Emotions Over Time 












































































#5, age 58 
(AncestryDNA, 
23andMe( 









































#8, age 44 
(AncestryDNA, 
23andMe) 
Excitement Excitement Excitement Excitement, 
Obsession 





















#10, age 40 
(AncestryDNA, 
Promethease) 











#11, age 46 
(23andMe, 
GEDMatch) 
Excitement Impatience Curiosity  Ambivalenc
e 




























#14, age 48 
(AncestryDNA, 
23andMe, 
FamilyTreeDNA, 
GEDMatch) 
Excitement Excitement Disappointm
ent 
(ancestry-
related), 
Curiosity 
(health-
related) 
Disappointm
ent 
(ancestry-
related) 
 
